# Neoadjuvant Chemoradiotherapy Versus Neoadjuvant Chemotherapy For Unresectable Locally Advanced Colon Cancer

> **NCT03970694** · PHASE3 · TERMINATED · sponsor: **Sun Yat-sen University** · enrollment: 49 (actual)

## Conditions studied

- Colon Cancer

## Interventions

- **RADIATION:** Radiotherapy
- **DRUG:** oxaliplatin+capecitabine

## Key facts

- **NCT ID:** NCT03970694
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-05-11
- **Primary completion:** 2022-05-30
- **Final completion:** 2022-06-05
- **Target enrollment:** 49 (ACTUAL)
- **Why stopped:** Significant differences in conversion rate as well as R0 resection rate between the two groups.
- **Last updated:** 2022-06-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03970694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03970694, "Neoadjuvant Chemoradiotherapy Versus Neoadjuvant Chemotherapy For Unresectable Locally Advanced Colon Cancer". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT03970694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*